RG2133 (2',3',5'-tri-O-acetyluridine)

TERMINATED · PHASE1 · Mitochondrial Diseases

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.